New Insights 2 Lemoyne

New Insights 2 Lemoyne, based in Lemoyne, PA, is one of the SAMHSA-registered treatment programs operating in PA. The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at New Insights 2 Lemoyne

The care-level question matters because what a facility offers is what it can realistically treat well. The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether New Insights 2 Lemoyne's offerings match the clinical need.

Insurance and payment

New Insights 2 Lemoyne accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Programs that cannot answer all three quickly are programs worth approaching with caution.